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Abstract: RADA16-I peptide hydrogel, a type of nanofiber scaffold derived from 
self-  assembling peptide RADA16-I, has been extensively applied to regenerative medicine and 
tissue repair in order to develop novel nanomedicine systems. In this study, using RADA16-I 
peptide hydrogel, a three-dimensional (3D) cell culture model was fabricated for in vitro cul-
ture of three ovarian cancer cell lines. Firstly, the peptide nanofiber scaffold was evaluated by 
transmission electron microscopy and atom force microscopy. Using phase contrast microscopy, 
the appearance of the representative ovarian cancer cells encapsulated in RADA16-I peptide 
hydrogel on days 1, 3, and 7 in 24-well Petri dishes was illustrated. The cancer cell–nanofiber 
scaffold construct was cultured for 5 days, and the ovarian cancer cells had actively proliferative 
potential. The precultured ovarian cancer cells exhibited nearly similar adhesion properties and 
invasion potentials in vitro between RADA16-I peptide nanofiber and type I collagen, which sug-
gested that RADA16-I peptide hydrogel had some similar characteristics to type I collagen. The 
precultured ovarian cancer cells had two-fold to five-fold higher anticancer drug resistance than 
the conventional two-dimensional Petri dish culture. So the 3D cell model on peptide nanofiber 
scaffold is an optimal type of cell pattern for anticancer drug screening and tumor biology.
Keywords: 3D culture, anticancer drug, nanofiber scaffold, cell viability, ovarian cancer
Introduction
Nanotechnology aims to construct novel materials and operative models in nanoscale 
dimensions. Several potential applications of nanotechnology in medicine can be 
envisioned, eg, targeted drug delivery systems, tissue engineering scaffolds, novel 
drug screening strategies, and micro/nanofluidic devices.1 Thus far, this field has made 
progress and merged new ideas. Molecular self-assembly has served as an alternative 
paradigm for preparing novel nanobiomaterial with a functional nanostructure. Self-
assembling peptide was discovered by Shuguang Zhang (Biomedical   Engineering 
Centre, Massachusetts Institute of Technology, MA, USA), who conformed to the 
‘bottom-up’ principles of engineering science. RADA16-I peptide hydrogel was 
designed to be a matrix scaffold that allows cells to reside in a three-dimensional (3D) 
microenvironment similar to cellular niches in vivo2 and be extensively applied to 
regenerative medicine and some novel drug delivery systems.3,4 The peptide sequence 
(AcN–RADARADARADARADA–CONH2) promoted cell attachment and migration 
of normal primary somatic cells and some derived stem cells.5,6 Recently, some self-
assembling peptides were functionalized by functional motifs with a link of two glycine International Journal of Nanomedicine 2011:5 submit your manuscript | www.dovepress.com
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residues at the C terminus. The designer self-assembling 
peptides enhanced osteoblasts and adult mouse neural stem 
cell proliferation, differentiation, and 3D migration, which 
suggests that this novel nanofiber scaffold was a new type of 
biologically inspired nanomaterial for regenerative medicine 
and tissue repair.7,8 Consequently, self-assembling peptide-
based 3D cell culture models are becoming much more 
useful research tools in modern biomedical investigations, 
but studies of cancer cell lines grown on this novel nanofiber 
scaffold, in particular in gynecological oncology, are limited 
and have provided few insights into tumor biology and anti-
cancer drug screening.
Epithelial ovarian cancer is often an aggressive disease 
and is typically diagnosed at an advanced stage when thera-
peutic resistance occurs, for reasons as yet unknown. There 
are very few studies describing 3D cell culture models for 
ovarian cancer, which is still poorly understood, and the 
standard chemotherapeutic regimes are nonspecific. If an 
elaborate cell culture model that accurately mimics ovarian 
cancer in vivo can be developed in vitro, the underlying 
biology of the cancer could be explored and some extensive 
understanding could be achieved. So the 3D in vitro cell line 
models are particularly significant for ovarian cancer. They 
may be extremely useful tools in gynecological oncology to 
investigate cellular or molecular events and develop novel 
anticancer drugs.
In this study, a 3D cell culture model was explored that 
may provide a type of cell pattern and skills to evaluate the 
features of peptide nanofiber scaffold and precultured cancer 
cells. In this article, the ovarian cancer cell lines A2780, 
A2780/DDP, and SK-OV-3 were seeded in RADA16-I 
peptide hydrogel for the evaluation of their morphology, 
adhesion, migration, and chemotherapeutic assay. The 3D 
cell culture model is an effective tool and preferable for anti-
cancer drug screening and investigations of tumor biology.
Materials and methods
Materials
The peptide RADA16-I, [COCH3]-RADARADARADARA-
DARADA-[CONH2] (molecular weight, 1712 kDa), is com-
mercially available under the name of PuramatrixTM hydrogel 
(3DM Inc, Cambridge, MA, USA), which comes packaged as 
1% (w/v). RADA16-I peptide hydrogel has an approximate 
pH value of 4.0 in its packaged state. 3-(4,5-Dimethylth-
iazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) was 
purchased from Sigma-Aldrich (St Louis, MO, USA). The 
human ovarian cancer cell lines A2780, A2780/DDP, and 
SK-OV-3 were purchased from the American Type Culture 
Collection (Rockville, MD, USA) and provided by Dr 
Jinliang Yang at State Key Laboratory of Biotherapy and 
Cancer Center (Sichuan University, Chengdu, China). To 
culture ovarian cancer cell lines, penicillin/streptomycin, 
the media (RPMI-1640, used for A2780 and A2780/DDP; 
McCoy’s 5a Medium, used for SK-OV-3), and fetal bovine 
serum (FBS) were obtained from Invitrogen (Shanghai, 
China). Rat-tail type I collagen (3.56 mg/mL) was purchased 
from BD Biosciences Inc (San Jose, CA, USA). Anticancer 
drugs 5-fluorouracil (5-FU), paclitaxel, and curcumin were 
all purchased from Sigma. All other reagents and solvents 
were commercially available.
Structural assessment of RADA16-I  
peptide nanofiber
The RADA16-I peptide hydrogel at 1% (w/v) was prepared 
in Milli-Q H2O for the transmission electron microscopy 
as described by Mi et al.9 An aliquot of 1 µL was removed 
and diluted with 19 µL of Milli-Q H2O (20× dilutions). 
Five microliters of the solution were immediately deposited 
homogeneously on a freshly cleaved mica surface (about 
10 × 10 mm2). Each aliquot was left on the mica for 30 sec 
and then rinsed with 100 µL of Milli-Q H2O to remove unat-
tached peptides. The peptide sample on the mica surface was 
then air dried, and the images were acquired immediately 
by scanning the mica surface by atom force microscopy 
(AFM) (Seiko Instruments Inc, Chiba, Japan), operating in 
tapping mode. Soft silicon cantilevers were chosen, with a 
length of 219 µm and a spring constant of 3 N/m. The tip 
radius of curvature was 5 nm. AFM scans were recorded at 
512 × 512 pixels resolution and produced topographic images 
in which the brightness of the sample increased as a function 
of height. Typical scanning parameters have been described.10 
All image data were subjected to first-order flattening to 
dispel any distortion, such as reversal of causeless drifting, 
vibration, and creep of the scanner. AFM observation of each 
sample was repeated at least three times.
Casting of ovarian cancer cells–seeded  
hydrogel and 3D cell culture
For fabricating the ovarian cancer cell–nanofiber scaffold 
construct, the recommended final concentration of nano-
fiber scaffold was 0.5% (w/v). By using a 1:1 dilution of 
RADA16-I peptide hydrogel to cell suspension in a 20% 
sucrose, the final concentrations of nanofiber scaffold and 
sucrose were 0.5% and 10%, respectively. The cancer cells 
of A2780, A2780/DDP, and SK-OV-3 at about 80%–85% 
confluence were harvested and resuspended in 20% sucrose International Journal of Nanomedicine 2011:5 submit your manuscript | www.dovepress.com
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at the concentration of 1.0 × 106 cells/mL. The cancer cell 
suspension was quickly mixed with an equal volume of 
RADA16-I peptide hydrogel, and 50 µL of the mixture was 
quickly loaded into the top portion of each well in a 24-well 
Petri dish (100 µL for 12-well Petri dish) before 250 µL of the 
culture medium was immediately added to the bottom portion 
of each well (500 µL for a 12-well Petri dish). The seeding 
density was fixed at a viable cell concentration of 1.0 × 106 
cells/cm2. The addition of a cell medium caused RADA16-I 
peptide hydrogel to self-assemble or gel in about 30–60 min 
and encapsulate cancer cells in a 3D microenvironment. The 
media were changed twice in the next 30 min, and care was 
taken not to aspirate the top portion of the Petri dish. The 
procedure of 3D cell culture was performed over 7 days, and 
the media were replaced every other day.
To assess the cell proliferation in 3D cell culture, the 
cell viability was analyzed by the assay at the desired time. 
All cell cultures were made in the complete medium with 
10% FBS and antibiotics in a humidified atmosphere under 
5% CO2 at 37°C. The cancer cells (5 × 104 cells/well) were 
seeded on the nanofiber scaffold in a 24-well Petri dish. The 
cell proliferation was monitored by an MTT assay for 1, 3, 5, 
and 7 days with a microplate reader (Bio-Rad Inc, Hercules, 
CA, USA). The mechanism of this assay is that biologically 
active cells react with tetrazolium salt in the MTT reagent to 
produce water-insoluble formazan dye that can be observed 
at 570 nm.
Adhesion assay
The adhesion assays of the ovarian cancer cells on the 
peptide nanofiber scaffold and type I collagen scaffold 
(1.78 mg/mL) were performed as previously described 
with some modifications.11 Ninety-six-well flat-bottom 
poly(vinyl chloride) (PVC) titer plates were coated with 
50 µL of RADA16-I peptide hydrogel and type I collagen, 
following incubation overnight at 4°C. The self-assembly 
process of peptide nanofiber was initiated by adding 50 µL 
of phosphate-buffered saline (PBS) to the plate. The hydro-
gel solution was then removed and the wells were washed 
twice with PBS and incubated with 10 mg/mL bovine serum 
albumin (BSA) in PBS for 30 min to block the uncoated 
PVC surface. The wells were rinsed twice with PBS before 
the addition of cells. For the adhesion assay, the ovarian 
cancer cells were collected for use after being cultured for 
5 days in a 3D cell culture model. The cancer cell layer 
was rinsed with the ice-cold PBS and scraped into PBS on 
ice and counted in a hemacytometer. The cell suspension 
was diluted to obtain a concentration of 1.0 × 105 cells/mL. 
About 50 µL of cell suspension was added to each well and 
incubated at 37°C for 4 h, and then the cell suspension was 
removed from the wells, which were rinsed twice with PBS. 
The cancer cells in the well were measured by an MTT 
assay. Adhesion assay of each ovarian cancer cell line was 
carried out at least in triplicate.
Migration and invasion assay
In order to explore the migration and invasion potential of 
ovarian cancer cells on the peptide nanofiber scaffold, a 
model of tumor cell migration and invasion was established 
on the basis of the conventional transwell model as intro-
duced previously.12–14 Millicell-polycarbonate (PCF) insert 
(Millipore, Billerica, MA, USA) was used for the cell migra-
tion and invasion assay. The chamber consisted of a 24-well 
plate and Millicell insert, a transparent PCF membrane 
with 8-µm pore size. First, the millicell inserts were coated 
with a thin layer of RADA16-I peptide hydrogel or type I 
collagen solution. The precultured cancer cells of A2780, 
A2780/DDP, and SK-OV-3 were resuspended in the starva-
tion medium, the complete medium containing 1% FBS, to 
prepare the condition medium for use. Ovarian cancer cells 
(1 × 105 cells/mL) of 100 µL were added to the inserts and 
incubated at 37°C for 24 h. The cancer cells adhered to the 
upper side of the membrane were removed gently with a 
cotton swab and rinsed with PBS. The cells that migrated 
through the membrane and adhered to the bottom of the 
membrane were fixed in 4% paraformaldehyde and stained 
with 0.1% crystal violet. The PCF membrane was cut out 
and photographed. This assay was performed in triplicate for 
every ovarian cancer cell line.
Chemotherapeutic assay
In order to evaluate the chemotherapeutic effect of the anti-
cancer drug in a 3D cell culture model, the IC50 value, which 
was the mean of the concentration of anticancer drug achiev-
ing a 50% inhibition of cell viability as compared with the 
untreated cell control, was firstly determined in the conven-
tional two-dimensional (2D) Petri dish. 5-FU, paclitaxel, and 
curcumin were dissolved in dimethyl sulfoxide at 100 mM as 
stock solutions and diluted to the proper concentration with 
culture medium. A2780, A2780/DDP, and SK-OV-3 cells 
were cultured in a 24-well Petri dish at a cell density of 
5 × 104 cells/well for 24 h in the complete media. For drug 
treatment, the culture medium was renewed with a fresh 
medium containing the proper concentration of the anticancer 
drug, and then the cancer cells were incubated for another 
24 h. The cell viability was determined by MTT assay.International Journal of Nanomedicine 2011:5
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Figure  1  Molecular  self-assembling  peptide  RADA16-I  was  evaluated  by  TEM 
and AFM. A) Molecular model of RADA16-I with 16 amino acid residues and the 
alternating  positive  and  negative  residue’s  arrangement.  B)  TEM  of  RADA16-I 
peptide nanofiber (magnified ×40,000). C) The interwoven nanofiber networks of 
RADA16-I peptide by AFM scan. D) High-resolution deflection image of RADA16-I 
peptide nanofiber. The nanofiber scaffold presented here was observed at least 
three times.
Abbreviations:  TEM,  transmission  electron  microscopy;  AFM,  atom  force 
microscopy.
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The ovarian cancer cells of A2780, A2780/DDP, and SK-
OV-3 were seeded on the peptide nanofiber scaffold in a 12-well 
Petri dish and cultured for 5 days in the media before adding 
the anticancer drugs. The culture medium was renewed with 
the fresh medium containing two-fold to five-fold IC50 con-
centration of the anticancer drug. Chemotherapeutic effect was 
evaluated by an MTT assay after another 24-h incubation.
Statistics
All data were expressed as mean ± standard deviation and 
an ANONA and Student’s t-test were conducted with SPSS 
version 13.0 software (SPSS, Chicago, IL, USA). Results for 
all analyses with a P value , 0.05 indicated the statistically 
significant differences (*P , 0.05; **P , 0.01).
Results and discussion
Molecular characterization  
of RADA16-I peptide nanofiber scaffold
Molecular self-assembling peptide RADA16-I derived 
from a Lego peptide segment of Zuotin, a left-handed 
Z-DNA-binding protein originally discovered in yeast, with 
alternating alanine and amino acid residues, has recently 
emerged as a novel nanobiomaterial for regenerative medicine 
and tissue repair.15–17 RADA16-I peptide served as the building 
block of nanofiber scaffold ≈10 nm in diameter with the drive 
of positively and negatively charged residues by complemen-
tary ionic interactions and spontaneously assembled into the 
well-ordered nanofiber networks with the pore size of about 
5–200 nm (  Figure 1A and B). When dissolved in Milli-Q 
H2O, RADA16-I peptide existed as the stable hydrogel with 
extremely high water content (.99.5%) at 1–5 mg/mL (w/v). 
The in situ AFM scan exhibited that RADA16-I peptide 
nanofiber scaffold consisted of the nanofiber with length 
1019.83 ± 90.16 nm and diameter 32.37 ± 1.72 nm (Figure 1C 
and D), which closely mimicked the porosity and gross struc-
ture of extracellular matrices (ECMs) and was suitable for the 
fabrication of the artificial cell niches for the applications of 
tumor biology and regenerative medicine. When desired, the 
cancer cells could be easily encapsulated into the nanofiber 
networks in a truly 3D microenvironment. When mixed with 
the ovarian cancer cells, the peptide nanofiber hydrogel formed 
the regular cancer cell–nanofiber scaffold construct, which was 
readily mounted on the bottom of the wells in a Petri dish. The 
cancer cells were evenly distributed and enabled the user to 
develop the different cell patterns in line with the particular 
purpose of cell biology. The operation procedure was very 
simple and convenient in the laboratory.
Morphology and proliferation  
of ovarian cancer cells
As 3D cell models for ovarian cancer, A2780, A2780/DDP, 
and SK-OV-3 cell lines were chosen; the A2780 cells had 
nearly the same features as A2780/DDP, besides the different 
drug resistance. SK-OV-3 cells had slow growth activity. The 
ovarian cancer cell–peptide nanofiber construct cast in the 
24-well Petri dish was of a particular transparent morphology 
that enabled the convenient capture of cell images by the phase 
contrast microscopy. The cancer cell–peptide nanofiber scaffold 
interactions were intimate and clear-cut in appearance. The 
peptide nanofibers were densely enmeshed with each other, 
and the cancer cells gradually integrated with the surround-
ing nanofibers as cell growth proceeded. On the first day, the 
cancer cells of A2780, A2780/DDP, and SK-OV-3 were evenly 
distributed and maintained inherent morphology (Figure 2A, 
D, and G). After 3 days, cell density increased; simultaneously, 
the cells closed up and presented distinctive appearances. 
A2780 and A2780/DDP cells initially formed cell colonies, 
whereas SK-OV-3 cells proliferated slowly and maintained 
their individual cellular appearance (Figure 2B, E, and H). 
After 7 days, A2780 and A2780/DDP cells formed the multi-
cellular spheroids   (Figure 2C and F), whereas SK-OV-3 cells 
formed the cell clusters (Figure 2I), which were the typical 
morphologies of cancer cells in 3D cell culture and the   common International Journal of Nanomedicine 2011:5
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Figure 2 Phase contrast microscopy images of A–C) A2780, D–F) A2780/DDP, 
and G–I) SK-OV-3 cultured in RADA16-I peptide hydrogel on days 1, 3, and 7. The 
arrows indicate multicellular spheroids, cell clusters, or cell colonies. A, D, and G) 
indicate the initial cell morphology on the first day. B, E, and H) indicate the cell 
colonies of A2780, A2780/DDP, and SK-OV-3 after 3 days. C, F, and I) indicate the 
multicellular spheroids of A2780 and A2780/DDP and the cell clusters of SK-OV-3 
after 7 days. All images are captured at ×200 magnification.
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Figure 3 Cell viability of three ovarian cancer cell lines as a function of culture time. 
5 × 104 cells were seeded on the peptide nanofiber scaffold and monitored by an 
MTT assay with a microplate reader.
Abbreviation: MTT, 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide.
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  characteristics of the glandular epithelial tumors. As 3D cell 
culture continued, the cell morphologies of A2780, A2780/DDP, 
and SK-OV-3 cells maintained the inherent characteristics, and 
SK-OV-3 cells did not form the multicellular spheroids. The 
more detailed morphologies of A2780, A2780/DDP, and SK-
OV-3 cells were difficult to observe in the laboratory. The use 
of RADA16-I peptide hydrogel to culture cancer cells should 
improve our understanding of the disease and allow us to 
assess treatment response in more clinically predictive model 
systems.18 RADA16-I peptide hydrogel conferred an elaborate 
3D microenvironment for cancer cells in response to the sur-
rounding topography. The 3D cell culture model was a simple 
cell encapsulating methodology and an optimal strategy for 
tumor biology and regenerative medicine.
Cancer cell viability
MTT assay was performed to assess the cell viability of three 
ovarian cancer cell lines on a peptide nanofiber scaffold. In a 3D 
cell culture procedure, very few cancer cells underwent apop-
tosis and necrosis. As Figure 3 indicates, the cell proliferation 
of three ovarian cancer cell lines exhibited similar cell viability 
in a 3D cell culture model, although SK-OV-3 cells proliferated 
slowly. When cultured for 5 days, all three ovarian cancer lines 
showed the significantly higher proliferative activity, indicating 
that ovarian cancer cells acclimatized themselves to the 3D 
microenvironment of a peptide nanofiber scaffold. It is unani-
mously recognized that the in vivo microenvironment of cancer 
cells is key to metastasis and tumor progression. The peptide 
nanofiber hydrogel formed the elaborate 3D microenviron-
ment that was similar to the tumor in vivo and facilitated the 
maintenance of the inherent malignant phenotype of the ovarian 
cancer cells. Recent progress in bioengineered tumor models 
has revealed that the nanofiber scaffold is suitable for cancer cell 
growth and survival. The nanofiber scaffold potentially provides 
some functionalities for cell proliferation, adhesion, migration, 
invasion, and phenotype presentations.19,20 The cell morphology 
and cancer cell–nanofiber scaffold construct were studied for 
7 days. When cultured in the 3D model for 5 days, the ovarian 
cancer cells exhibited actively proliferative potential, which 
encourages investigation in tumor biology and may lead to the 
discovery of anticancer drugs.
Adhesion of ovarian cancer  
cells on the peptide nanofiber
The cell–matrices interaction was an important determinant 
of cancer cell behavior and tumorigenesis. Type I collagen 
was a structural protein in the ECMs and was widely used 
as a scaffold and promoter for cell adhesion. The natural 
fibrous structure of type I collagen could promote the cells 
to attach to the interstitial matrix.21 The precultured ovar-
ian cancer cells of A2780, A2780/DDP, and SK-OV-3 all 
showed significant attachment potential to type I collagen 
and the peptide nanofiber scaffold as compared with the 
control BSA. No significant adhesion difference occurred 
between type I collagen and the peptide nanofiber scaffold 
(Figure 4A). The adhesion percentages of type I collagen 
and the peptide nanofiber scaffold also had no significant International Journal of Nanomedicine 2011:5
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Figure 4 Adhesion behavior of the precultured A2780, A2780/DDP, and SK-OV-3 cells. A) The number of adhesion cells on the type I collagen, the peptide nanofiber, and 
BSA (control). B) The adhesion percentage of the precultured A2780, A2780/DDP, and SK-OV-3 cells on the scaffolds. The assay was conducted at least in triplicate.
Abbreviation: BSA, bovine serum albumin.
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Figure 5 The migration and invasion of the precultured A2780, A2780/DDP, and 
SK-OV-3 cells. Relative normalized cell number per area was counted under the 
condition of phase contrast microscopy. This assay was performed in triplicate for 
every ovarian cancer cell line.
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statistical   differences (Figure 4B), which suggested that 
self-assembling peptide RADA16-I nanofiber scaffold had 
some similar characteristics of type I collagen. Thus far, in 
the case of neural stem cells, RADA16-I peptide nanofiber 
scaffold has comprehensively been compared with the most 
commonly used scaffolds, including PLLA, PLGA, PCLA, 
type I collagen, type IV collagen, and Matrigel, which indi-
cates that RADA16-I peptide nanofiber scaffold represents 
a new class of functionalized and biologically active nano-
fiber scaffold.22 The well-defined nanofiber networks and 
the characteristics of the high H2O content make it a very 
attractive class of biological nanomaterial. It is favorable for 
cell adhesion and differentiation.23 Broadly, these studies are 
consistent with our data. So the 3D cell model developed in 
this study was a good representation of the primary tumor 
and likely to simulate the in vivo biological characteristics 
of ovarian cancer cells.24
Migration and invasion  
of the ovarian cancer cells
When ovarian cancer cells were able to adhere to the peptide 
nanofiber scaffold, whether these ovarian cancer cells were 
able to migrate or infiltrate the nanofiber matrices in the 3D 
model was investigated. As Figure 5 indicates, three ovarian 
cancer cell lines readily adhered to the peptide nanofiber scaf-
fold and invaded the gelled peptide hydrogel matrices after 
24-h culture. There was no significant difference between the 
number of migrating cancer cells for type I collagen and the 
peptide nanofiber scaffold, which suggests that the peptide 
nanofiber scaffold had some biological functionalities that 
were similar to type I collagen and facilitated the maintenance 
of the malignant phenotypes of ovarian cancer cells or the 
invasion potentials. Although the molecular mechanisms of 
the cancer cells’ adhesion and invasion were delicate in both 
normal and pathological conditions, in the case of highly 
aggressive ovarian cancer cells, it was imperative that the 
basic molecular or cellular events remained to be elucidated 
in a defined cell culture model. So the 3D cell culture model 
in this study offered a type of cell pattern to explore the 
topographical features at nanoscale comparable with the 
scale of the ECM components and the biological activities of 
tumorigenesis, metastasis, and colonization.16,17,23,25,26
Chemotherapeutic assay  
of anticancer drugs
In the anticancer drug screening laboratory, the 2D cell 
culture was often used to monitor the cytostatic effects of 
the different anticancer drugs; the malignant cells were only 
able to obtain cell viability and increase the cell number. In 
contrast, a 3D cell culture model fabricated on the nanofiber 
scaffold conferred on the precultured cancer cells some 
cellular functionalities to enable them to survive in the   International Journal of Nanomedicine 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
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in vivo microenvironment and profoundly affect the response 
of the ovarian cancer cells to chemotherapeutic drugs. The 
precultured ovarian cancer cells exhibited increased resis-
tance compared with the cancer cells in 2D Petri dish culture 
(Table 1). Initially, the IC50 concentrations of 5-FU, paclitaxel, 
and curcumin were determined. The precultured ovarian can-
cer cells needed two-fold to five-fold higher concentrations 
of the anticancer drugs to reach more than 50% inhibition 
activity, as described in Figure 6, indicating that the chemo-
therapeutic resistance was derived from the inherent properties 
of the precultured ovarian cancer cells. The 3D cell culture 
model may have provided a cancerous microenvironment that 
was more reflective of the tumor in vivo.27 Tumorigenesis was 
related to the cancer cell–matrices microenvironment, which 
determined how aggressive the tumor might be and how to 
respond to the chemotherapeutic intervention.24 The cell cul-
ture operations on the peptide nanofiber scaffold are simple 
and easy to set up, and the maintenance of cell lines is also 
simple. So the 3D cell model may be used in technological 
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Figure 6 Chemotherapeutic effects of the anticancer drugs against the precultured 
ovarian cancer cells. Cancer cells in the conventional two-dimensional Petri dish and 
the precultured cancer cells in peptide nanofiber scaffold were evaluated by the cell 
viability after 24-h incubation. 
Abbreviation: 5-FU, 5-fluorouracil.
Table 1 IC50 concentration in the 2D Petri dish culture and 
chemotherapeutic assay in the 3D model
Anticancer  
drug
Tested concentration  
(μg/mL)
IC50 (μg/mL) 3D model   
(μg/mL)
5-FU 1–500 120 350
Paclitaxel 1–500 90 370
Curcumin 1–300 35 80
Note: The concentration values were determined using 5 × 104 cell number.
Abbreviations: 2D, two-dimensional; 3D, three-dimensional; 5-FU, 5-fluorouracil; 
IC50, mean of the concentration of anticancer drug achieving a 50% inhibition of cell 
viability.
development for anticancer drug screening and is particularly 
useful in guiding the treatment regimes for untraceable cancer-
ous diseases with high mortality. Other studies are underway 
in our laboratory to explore the molecular markers specifically 
relevant to the progression of epithelial ovarian cancer cells 
grown in 3D cell patterns and to test the anticancer drugs in 
orthotopic mouse models.
Conclusion
In this study, the molecular self-assembling peptide RADA16-I 
forms a well-ordered nanofiber network and stable hydrogel. 
The cell casting procedure is simple and enables a rapid 
and efficient encapsulation of ovarian cancer cells within 
RADA16-I peptide hydrogel. Encapsulated cells are evenly 
distributed throughout the hydrogel. The ovarian cancer cells 
exhibit actively proliferative activities and maintain the inher-
ent characteristics of cell morphology. Furthermore, compared 
with type I collagen, the most common ECM, RADA16-I 
peptide nanofiber, is preferable for ovarian cancer cell lines to 
adhere and migrate in a 3D environment. Interestingly, com-
pared with the conventional 2D Petri dish culture, the precul-
tured ovarian cancer cells exhibit obviously higher therapeutic 
resistance to anticancer drugs, including 5-FU, paclitaxel, and 
curcumin. So a 3D cell culture model in RADA16-I peptide 
hydrogel can be particularly useful for anticancer drug screen-
ing and in vitro investigation of tumor biology. RADA16-I 
peptide hydrogel is a significant advance in nanobiomaterial 
innovation and provides an effective type of cell pattern for 
regenerative medicine and tumor biology.
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